AVXL
Price
$5.69
Change
-$1.21 (-17.54%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
594.39M
39 days until earnings call
Intraday BUY SELL Signals
JSPR
Price
$1.60
Change
-$0.17 (-9.60%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
49.53M
Intraday BUY SELL Signals
Interact to see
Advertisement

AVXL vs JSPR

Header iconAVXL vs JSPR Comparison
Open Charts AVXL vs JSPRBanner chart's image
Anavex Life Sciences
Price$5.69
Change-$1.21 (-17.54%)
Volume$60.55K
Capitalization594.39M
Jasper Therapeutics
Price$1.60
Change-$0.17 (-9.60%)
Volume$9.8K
Capitalization49.53M
AVXL vs JSPR Comparison Chart in %
AVXL
Daily Signal:
Gain/Loss:
JSPR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVXL vs. JSPR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and JSPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AVXL: $6.90 vs. JSPR: $1.77)
Brand notoriety: AVXL and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 126% vs. JSPR: 160%
Market capitalization -- AVXL: $594.39M vs. JSPR: $49.53M
AVXL [@Biotechnology] is valued at $594.39M. JSPR’s [@Biotechnology] market capitalization is $49.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 1 green, 4 red.
According to our system of comparison, JSPR is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 6 bearish.
  • JSPR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а -5.61% price change this week, while JSPR (@Biotechnology) price change was -9.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($594M) has a higher market cap than JSPR($49.5M). AVXL YTD gains are higher at: -35.754 vs. JSPR (-91.721). AVXL has higher annual earnings (EBITDA): -45.88M vs. JSPR (-92.73M). AVXL has more cash in the bank: 101M vs. JSPR (39.5M). AVXL has less debt than JSPR: AVXL (88.2K) vs JSPR (2.16M). AVXL (0) and JSPR (0) have equivalent revenues.
AVXLJSPRAVXL / JSPR
Capitalization594M49.5M1,200%
EBITDA-45.88M-92.73M49%
Gain YTD-35.754-91.72139%
P/E RatioN/AN/A-
Revenue00-
Total Cash101M39.5M256%
Total Debt88.2K2.16M4%
FUNDAMENTALS RATINGS
AVXL vs JSPR: Fundamental Ratings
AVXL
JSPR
OUTLOOK RATING
1..100
5376
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
8996
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JSPR's Valuation (35) in the null industry is in the same range as AVXL (41) in the Biotechnology industry. This means that JSPR’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as JSPR (100) in the null industry. This means that AVXL’s stock grew similarly to JSPR’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as JSPR (99) in the null industry. This means that AVXL’s stock grew similarly to JSPR’s over the last 12 months.

AVXL's Price Growth Rating (89) in the Biotechnology industry is in the same range as JSPR (96) in the null industry. This means that AVXL’s stock grew similarly to JSPR’s over the last 12 months.

JSPR's P/E Growth Rating (4) in the null industry is significantly better than the same rating for AVXL (100) in the Biotechnology industry. This means that JSPR’s stock grew significantly faster than AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLJSPR
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 24 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signal:
Gain/Loss:
JSPR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSLOY14.380.19
+1.30%
Mitsui O.S.K. Lines Ltd.
FTGFF7.910.03
+0.38%
Firan Technology Group Corporation
UELMO60.82N/A
N/A
Union Electric Co.
OLNCF1.22-0.11
-8.61%
Omni-Lite Industries Canada Inc.
NTSGF1.39-0.16
-10.58%
NATIONAL STORAGE REIT

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+0.73%
PLRX - AVXL
48%
Loosely correlated
+7.78%
TENX - AVXL
47%
Loosely correlated
-0.71%
AXON - AVXL
45%
Loosely correlated
-0.47%
VCYT - AVXL
41%
Loosely correlated
-0.84%
ARRY - AVXL
41%
Loosely correlated
-8.69%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
+4.12%
AUPH - JSPR
44%
Loosely correlated
-0.89%
ETHZ - JSPR
38%
Loosely correlated
+0.89%
AVXL - JSPR
35%
Loosely correlated
+0.73%
DSGN - JSPR
34%
Loosely correlated
-1.93%
APGE - JSPR
34%
Loosely correlated
+0.24%
More